Paul N. Span
Cancer, Hypoxia, and Metabolism · Cancer Research
Grants
No NSF/NIH grants on record.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 16 of 16Radiotherapy and Oncology · 2026-06-03
Radiobiological effects of CAIX-targeted alpha therapy in a hypoxic B16F10-OVA spheroid model
Journal of medical imaging and radiation sciences · 2026-03-01
Current insights into monitoring of congenital adrenal hyperplasia
Frontiers in Endocrinology · 2026-02-13
Communications Medicine · 2026-01-16 · 1 citations
The Journal of Clinical Endocrinology & Metabolism · 2025-08-06
Radiotherapy and Oncology · 2025-05-01
2606 MitoTam as OXPHOS inhibitor: reducing hypoxia in solid tumors
Radiotherapy and Oncology · 2025-05-01
1352 Targeted breast cancer radiosensitization using polymeric aptamers
Radiotherapy and Oncology · 2025-05-01
Clinical Cancer Research · 2025-02-03 · 25 citations
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models
Clinical and Translational Radiation Oncology · 2024-10-14 · 8 citations
Clinical & Translational Immunology · 2024-09-01 · 7 citations
Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia
The Journal of Clinical Endocrinology & Metabolism · 2024-08-25 · 5 citations
MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells
Radiotherapy and Oncology · 2024-08-24 · 12 citations
46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description
Frontiers in Endocrinology · 2024-08-08 · 7 citations
Molecular Imaging and Biology · 2024-07-15 · 9 citations
Free cortisol and free 21-deoxycortisol in the clinical evaluation of congenital adrenal hyperplasiaPreprint
medRxiv · 2024-07-11 · 1 citations